Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Total Environ ; 918: 170646, 2024 Mar 25.
Article in English | MEDLINE | ID: mdl-38325481

ABSTRACT

Major floods pose a severe threat to coastal receiving environments, negatively impacting environmental health and ecosystem services through direct smothering with sediment and nutrient loading. This study examined the short and long-term impacts of the February 2022 major flood event on mud extent and sediment nitrogen flux in Moreton Bay (the Bay), a large, sub-tropical embayment in Southeast Queensland, Australia. Short-term impacts were assessed three days after the flood peak by sampling surface water at 47 sites in the direction of the predominant circulation pattern. Longer-term impacts were assessed by undertaking an intensive sediment survey of 223 sites and a nutrient flux experiment using sediment core incubations to simulate calm and resuspension conditions for the four key sediment classes. Short-term impacts revealed elevated turbidity levels extended across the Bay but were highest at the Brisbane River mouth, ammonium concentrations varied inversely with surface turbidity, whereas nitrate concentrates closely tracked surface turbidity. The sediment survey confirmed fine sediment deposition across 98 % of the Bay. Porewater within the upper 10 cm contained a standing pool of 280 t of ammonium, with concentrations more than three orders of magnitude higher than overlying surface waters. The nutrient flux experiment revealed an order of magnitude higher sediment ammonium flux rate in the sandy mud sediment class compared to the other sediment classes; and for simulated resuspension conditions compared to calm conditions for sand, muddy sand, and mud sediment classes. Scaling across the whole Bay, we estimated a mean annual sediment flux of 17,700 t/year ammonium, with a range of 13,500 to 21,900 t/year. Delivery of fine sediments by major floods over the last 50 years now impact >98 % of the benthic zone and provide a major loading pathway of available nitrogen to surface waters of Moreton Bay; representing a significant threat to ecosystem health.

2.
Mar Pollut Bull ; 170: 112671, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34217054

ABSTRACT

Past catchment practices can contribute to environmental impacts for decades following their cessation. We examine the distribution of the prevalent organochlorine pesticide, dichlorodiphenyltrichloroethane (DDT) and its metabolites (DDE, DDD) in the sediments of a sub-tropical river system (Brisbane River, Australia). This study aimed to identify sources of DDT, DDE, DDD into the lower reaches of the Brisbane River. Annual sediment sampling of the lower Brisbane River over a period of 15 years (2001-2015) revealed a significant increase in sediment DDT, DDE and DDD content following major floods. A regional survey detected elevated sediment DDT, DDE and DDD content at 32 of 79 sites sampled; however, these were generally below guideline trigger values. DDE was the sole fraction at all but one site with creek systems dominated by intensive cropping practices identified as legacy sources and major flood events as a driver of elevated sediment DDE content in the lower reaches.


Subject(s)
Hydrocarbons, Chlorinated , Pesticides , Water Pollutants, Chemical , DDT/analysis , Dichlorodiphenyl Dichloroethylene/analysis , Environmental Monitoring , Geologic Sediments , Hydrocarbons, Chlorinated/analysis , Pesticides/analysis , Rivers , Water Pollutants, Chemical/analysis
3.
J Proteome Res ; 12(5): 2045-54, 2013 May 03.
Article in English | MEDLINE | ID: mdl-23432411

ABSTRACT

HIV-1 incorporates a large array of host proteins into virions. Determining the host protein composition in HIV virions has technical difficulties, including copurification of microvesicles. We developed an alternative purification technique using cholesterol that differentially modulates the density of virions and microvesicles (density modification, DM) allowing for high-yield virion purification that is essential for tandem mass spectrometric and quantitative proteomic (iTRAQ) analysis. DM purified virions were analyzed using iTRAQ and validated against Optiprep (60% iodixanol) purified virions. We were able to characterize host protein incorporation in DM-purified HIV particles derived from CD4+ T-cell lines; we compared this data set to a reprocessed data set of monocyte-derived macrophages (MDM) derived HIV-1 using the same bioinformatics pipeline. Seventy-nine clustered proteins were shared between the MDM derived and T-cell derived data set. These clusters included an extensive collection of actin isoforms, HLA proteins, chaperones, and a handful of other proteins, many of which have previously been documented to interact with viral proteins. Other proteins of note were ERM proteins, the dynamin domain containing protein EH4, a phosphodiesterase, and cyclophilin A. As these proteins are incorporated in virions produced in both cell types, we hypothesize that these proteins may have direct interactions with viral proteins or may be important in the viral life cycle. Additionally, identified common set proteins are predicted to interact with >1000 related human proteins. Many of these secondary interacting proteins are reported to be incorporated into virions, including ERM proteins and adhesion molecules. Thus, only a few direct interactions between host and viral proteins may dictate the host protein composition in virions. Ultimately, interaction and expression differences in host proteins between cell types may drive virion phenotypic diversity, despite conserved viral protein-host protein interactions between cell types.


Subject(s)
HIV-1/metabolism , Proteome/metabolism , Virion/metabolism , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/virology , Cell Fractionation/methods , Cell Line , Centrifugation, Density Gradient , Cholesterol/chemistry , Cluster Analysis , HIV-1/chemistry , HIV-1/isolation & purification , Host-Pathogen Interactions , Humans , Proteome/chemistry , Proteome/isolation & purification , Subcellular Fractions/chemistry , Tandem Mass Spectrometry , Virion/chemistry , Virion/isolation & purification
4.
J Neuroimmune Pharmacol ; 7(2): 401-11, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21626125

ABSTRACT

Studies of the effects of drugs of abuse on HIV immune status, disease progression, and neuroAIDS have produced conflicting data and have not definitively shown whether this combination promotes cognitive impairment or disease progression. Using a consistent SIV-macaque model, we investigated the effects of cocaine on behavior, virologic parameters, and CNS inflammation. Macaques received either vehicle or chronic administration of behaviorally active doses of cocaine (1.7 or 3.2 mg/kg/day). Chronic cocaine administration reduced CD8+ T cell counts during acute and late stage infection but had no effect on CD4+ T cell counts. Low-dose cocaine-treated animals had lower CSF vRNA levels late in infection, but cocaine did not alter plasma viral load or vRNA or protein in brain. There were no differences in CSF CCL-2 or interleukin (IL)-6 levels or severity of encephalitis in cocaine-treated as compared to vehicle-treated macaques. There were no differences in brain inflammation or neurodegeneration markers, as determined by interferon (IFN)-ß, MxA, CCL2, IL-6, TNFα, IFNγ, and indolamine 2,3-deoxygenase mRNA levels. APP levels also were not altered. The executive function of inhibitory control was not impaired in cocaine-treated or control animals following SIV infection. However, animals receiving 3.2 mg/kg/day cocaine performed more slowly in a bimanual motor test. Thus, chronic administration of cocaine produced only minor changes in behavior, encephalitis severity, CNS inflammation/neurodegeneration, and virus replication in SIV-infected pigtailed macaques, suggesting that cocaine would have only modest effects on the progression of neuroAIDS in HIV-infected individuals.


Subject(s)
Behavior, Animal/drug effects , Brain/drug effects , Cocaine/pharmacology , Simian Acquired Immunodeficiency Syndrome/complications , Virus Replication/drug effects , Animals , Brain/immunology , Brain/pathology , CD4 Lymphocyte Count , CD8-Positive T-Lymphocytes/drug effects , Disease Models, Animal , Dopamine Uptake Inhibitors/pharmacology , Female , HIV Infections/complications , Immunohistochemistry , Inflammation/pathology , Macaca , Male , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Acquired Immunodeficiency Syndrome/pathology
5.
J Virol ; 85(15): 7699-709, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21613400

ABSTRACT

Cholesterol plays an essential role in the life cycle of several enveloped viruses. Many of these viruses manipulate host cholesterol metabolism to facilitate their replication. HIV-1 infection of CD4(+) T cells activates the sterol regulatory element-binding protein 2 (SREBP2) transcriptional program, which includes genes involved in cholesterol homeostasis. However, the role of SREBP2-dependent transcription in HIV-1 biology has not been fully examined. Here, we identify TFII-I, a gene critical for HIV-1 transcription in activated T cells, as a novel SREBP2 target gene. We found TFII-I expression increased after HIV-1 infection or activation of human primary CD4(+) T cells. We show that inhibition of SREBP2 activity reduced TFII-I induction in response to these stimuli. More importantly, small interfering RNA (siRNA)-mediated gene silencing of either SREBP2 or TFII-I significantly reduced HIV-1 production in CD4(+) T cells. We also found that TFII-I potentiates Tat-dependent viral gene expression, consistent with a role at the level of HIV-1 transcription. Collectively, our results demonstrate for the first time that HIV-1 transcription in T cells is linked to cholesterol homeostasis through control of TFII-I expression by SREBP2.


Subject(s)
Cholesterol/metabolism , HIV-1/genetics , Homeostasis/physiology , Lymphocyte Activation , Sterol Regulatory Element Binding Protein 2/physiology , T-Lymphocytes/immunology , Transcription, Genetic/physiology , Base Sequence , Cell Line , DNA Primers , Flow Cytometry , Humans , Protein Binding , Sterol Regulatory Element Binding Protein 2/metabolism , Transcription Factors, TFII/genetics
6.
Nucleic Acids Res ; 34(1): 275-85, 2006.
Article in English | MEDLINE | ID: mdl-16407334

ABSTRACT

Previous kinetic investigations of the N-terminal RNA recognition motif (RRM) domain of spliceosomal protein U1A, interacting with its RNA target U1 hairpin II, provided experimental evidence for a 'lure and lock' model of binding in which electrostatic interactions first guide the RNA to the protein, and close range interactions then lock the two molecules together. To further investigate the 'lure' step, here we examined the electrostatic roles of two sets of positively charged amino acids in U1A that do not make hydrogen bonds to the RNA: Lys20, Lys22 and Lys23 close to the RNA-binding site, and Arg7, Lys60 and Arg70, located on 'top' of the RRM domain, away from the RNA. Surface plasmon resonance-based kinetic studies, supplemented with salt dependence experiments and molecular dynamics simulation, indicate that Lys20 predominantly plays a role in association, while nearby residues Lys22 and Lys23 appear to be at least as important for complex stability. In contrast, kinetic analyses of residues away from the RNA indicate that they have a minimal effect on association and stability. Thus, well-positioned positively charged residues can be important for both initial complex formation and complex maintenance, illustrating the multiple roles of electrostatic interactions in protein-RNA complexes.


Subject(s)
Amino Acids, Basic/chemistry , RNA, Small Nuclear/chemistry , RNA-Binding Proteins/chemistry , Ribonucleoprotein, U1 Small Nuclear/chemistry , Amino Acid Sequence , Amino Acids, Basic/genetics , Computer Simulation , Kinetics , Models, Molecular , Molecular Sequence Data , Mutation , Protein Binding , RNA, Small Nuclear/metabolism , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Ribonucleoprotein, U1 Small Nuclear/genetics , Ribonucleoprotein, U1 Small Nuclear/metabolism , Sodium Chloride/pharmacology , Static Electricity
7.
Am J Vet Res ; 64(12): 1542-8, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14672434

ABSTRACT

OBJECTIVE: To evaluate the clinical response of sheep experimentally infected with Ehrlichia ruminantium to treatment with dimethyl sulfoxide (DMSO). ANIMALS: 32 Merino crossbred sheep. PROCEDURES: 16 sheep were infected with E ruminantium; 8 of these were treated twice daily with a 10% solution of DMSO (1 g/kg, i.v.) in polyionic fluid for 3 consecutive days. Treatment was initiated 2 days after the onset of clinical disease. Eight uninfected control sheep were similarly treated with DMSO. Placebo treatments (polyionic fluid administrations) were given to 8 infected and 8 uninfected sheep. Arterial and venous blood samples for blood gas and total plasma protein concentration measurements were collected daily (data from 5 days before until 6 days after onset of clinical disease were analyzed); physiologic variables and food consumption were also monitored. Gross pathologic findings and cytologic confirmation of the disease were recorded for the 16 infected sheep. RESULTS: Infected sheep treated with DMSO were able to maintain pulmonary gas exchange and had reduced pleural effusion and plasma protein loss, compared with infected untreated sheep that became hypoxic. Infected treated sheep developed an uncompensated metabolic acidosis. Uninfected treated sheep had reduced appetite, whereas uninfected untreated sheep maintained normal food intake. CONCLUSIONS AND CLINICAL RELEVANCE: Results of DMSO treatment in sheep with experimentally induced heartwater disease indicated that administration of this agent, in combination with specific antimicrobial treatment, may be of some benefit in treatment of naturally occurring disease.


Subject(s)
Dimethyl Sulfoxide/therapeutic use , Ehrlichia ruminantium/physiology , Free Radical Scavengers/therapeutic use , Heartwater Disease/drug therapy , Pulmonary Gas Exchange/drug effects , Sheep/microbiology , Acidosis/physiopathology , Acidosis/veterinary , Animals , Eating , Heartwater Disease/physiopathology , Pleural Effusion/physiopathology , Pleural Effusion/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL